Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 3sanofi-aventis Canada Inc.
02 2Sanofi-Aventis Canada Inc.
01 12169356
02 12310960
03 12586023
04 22622693
01 2SEVELAMER CARBONATE
02 3Sevelamer Carbonate
01 2POWDER FOR SUSPENSION
02 3Tablet
01 22014-08-10
02 12025-11-01
03 22026-09-12
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2025-11-01
Date Granted : 2012-03-13
Brand Name : RENVELA
Patent Number : 2586023
Filing Date : 2005-11-01
Strength per Unit : 800 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2025-11-01
Date Granted : 2012-03-13
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2014-08-10
Date Granted : 2003-05-27
Brand Name : RENVELA
Patent Number : 2310960
Filing Date : 1994-08-10
Strength per Unit : 800 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2014-08-10
Date Granted : 2003-05-27
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Patent Expiration Date : 2014-08-10
Date Granted : 2000-07-04
Brand Name : RENVELA
Patent Number : 2169356
Filing Date : 1994-08-10
Strength per Unit : 800 mg
Dosage Form : Tablet
Human Or VET : Human
Route of Administration : Oral
Patent Expiration Date : 2014-08-10
Date Granted : 2000-07-04
Patent Expiration Date : 2026-09-12
Date Granted : 2015-05-05
Brand Name : RENVELA
Patent Number : 2622693
Filing Date : 2006-09-12
Strength per Unit : 0.8 g
Dosage Form : POWDER FOR SUSPENSION
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2026-09-12
Date Granted : 2015-05-05
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Patent Expiration Date : 2026-09-12
Date Granted : 2015-05-05
Brand Name : RENVELA
Patent Number : 2622693
Filing Date : 2006-09-12
Strength per Unit : 2.4 g
Dosage Form : POWDER FOR SUSPENSION
Human Or VET : Human
Route of Administration : ORAL
Patent Expiration Date : 2026-09-12
Date Granted : 2015-05-05
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
